Method for treating cervical dystonia with botulinum toxin type B
AssigneeAllergan, Inc.
InventorsK. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
Life of this patent
Estimating the term…
Abstract
A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
Claims11
A method for treating cervical dystonia in a human patient, the method comprising the step of administering to a human patient at least 500 units of a botulinum toxin type B to treat cervical dystonia.
A method for treating cervical dystonia in a human patient, the method comprising the step of administering to a human patient an effective amount of botulinum toxin type B to treat cervical dystonia, wherein the botulinum toxin type B is administered by intramuscular injection, the administration of the botulinum toxin type B results in an alleviation of a symptom of the cervical dystonia within 1 day to about 7 days and the patient is administered at least 500 units of the botulinum toxin type B.
A method for treating cervical dystonia, the method comprising the step of administering to a human patient at least 500 units of a botulinum toxin type B, thereby reducing the severity of an abnormal head position symptom of cervical dystonia.
A method for treating cervical dystonia, the method comprising the step of administering to a human patient at least 500 units of a botulinum toxin type B, thereby reducing a neck pain symptom of cervical dystonia.
Dependencies are inferred from the claim text.